TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/22/2024
Back to search
Official data from USPTO
A ASTEX PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
11/26/2024
Trademark type
Combined
Nice classes
42, 44
Filing date
10/13/2011
Registration date
08/06/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/28/2023
Last transaction
11/26/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/12/2011
First use in commerce
12/04/2011
Drawing code
3
Owner type
24
Owner location
CAMBRIDGE, GB
Examiner
KEAN, AMY
Law office
M40
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a stylized letter "A" with the stylized words "ASTEX PHARMACEUTICALS" appearing to the right. The gray tones are to indicate shading.
Holders and representatives
Holders
ASTEX THERAPEUTICS LIMITED
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.
Representatives
Carole E. Klinger Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development services in the field of pharmaceuticals; providing medical and scientific health care research information in the field of pharmaceuticals and clinical trials; drug discovery services; biotechnology research; scientific research and analysis in the field of drug discovery and pharmaceutical drug development
Class 44
Providing information in the field of the diagnosticprophylactictherapeutic properties of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
56 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/22/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/22/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/22/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/15/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/15/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/15/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/10/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/28/2023
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/28/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/28/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/24/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
02/07/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/06/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/15/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/15/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/15/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/01/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/01/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/01/2019
E815
TEAS SECTION 8 & 15 RECEIVED
07/23/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/06/2018
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
04/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2017
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/11/2015
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/11/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
08/06/2013
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/02/2013
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
06/29/2013
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/25/2013
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/05/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/04/2013
DPCC
DIVISIONAL PROCESSING COMPLETE
06/04/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/21/2013
IUAF
USE AMENDMENT FILED
05/17/2013
DRRR
DIVISIONAL REQUEST RECEIVED
05/17/2013
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
05/17/2013
EISU
TEAS STATEMENT OF USE RECEIVED
05/17/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/20/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/25/2012
PUBO
PUBLISHED FOR OPPOSITION
09/25/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/05/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/20/2012
ALIE
ASSIGNED TO LIE
08/16/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/03/2012
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
02/07/2012
GPRA
PRIORITY ACTION E-MAILED
02/07/2012
CPRA
PRIORITY ACTION WRITTEN
02/07/2012
DOCK
ASSIGNED TO EXAMINER
02/01/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2011
NWAP
NEW APPLICATION ENTERED
10/17/2011
Continuous trademark protection
Get notified about every new filing that threatens A ASTEX PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.